Annual Current Liabilities
$2.34 M
-$1.65 M-41.35%
31 December 2023
Summary:
Enveric Biosciences annual total current liabilities is currently $2.34 million, with the most recent change of -$1.65 million (-41.35%) on 31 December 2023. During the last 3 years, it has risen by +$1.66 million (+243.97%). ENVB annual current liabilities is now -92.28% below its all-time high of $30.37 million, reached on 31 December 2017.ENVB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$839.20 K
+$193.90 K+30.05%
30 September 2024
Summary:
Enveric Biosciences quarterly total current liabilities is currently $839.20 thousand, with the most recent change of +$193.90 thousand (+30.05%) on 30 September 2024. Over the past year, it has dropped by -$3.34 million (-79.94%). ENVB quarterly current liabilities is now -97.34% below its all-time high of $31.49 million, reached on 30 September 2017.ENVB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENVB Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.4% | -79.9% |
| 3 y3 years | +244.0% | -61.2% |
| 5 y5 years | -84.0% | -93.7% |
ENVB Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -41.4% | +244.0% | -83.0% | +30.1% |
| 5 y | 5 years | -84.0% | +244.0% | -95.0% | +33.9% |
| alltime | all time | -92.3% | >+9999.0% | -97.3% | >+9999.0% |
Enveric Biosciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $839.20 K(+30.0%) |
| June 2024 | - | $645.30 K(-72.7%) |
| Mar 2024 | - | $2.37 M(+1.0%) |
| Dec 2023 | $2.34 M(-41.4%) | $2.34 M(-44.0%) |
| Sept 2023 | - | $4.18 M(-15.1%) |
| June 2023 | - | $4.93 M(+11.0%) |
| Mar 2023 | - | $4.44 M(+11.1%) |
| Dec 2022 | $4.00 M(+46.0%) | $4.00 M(+53.8%) |
| Sept 2022 | - | $2.60 M(+11.8%) |
| June 2022 | - | $2.32 M(+11.0%) |
| Mar 2022 | - | $2.09 M(-23.5%) |
| Dec 2021 | $2.74 M(+301.8%) | $2.74 M(+26.6%) |
| Sept 2021 | - | $2.16 M(+85.3%) |
| June 2021 | - | $1.17 M(+86.2%) |
| Mar 2021 | - | $626.90 K(-8.0%) |
| Dec 2020 | $681.30 K(-95.3%) | $681.30 K(-95.1%) |
| Sept 2020 | - | $13.99 M(+9.6%) |
| June 2020 | - | $12.77 M(-24.5%) |
| Mar 2020 | - | $16.91 M(+17.6%) |
| Dec 2019 | $14.38 M(-2.1%) | $14.38 M(+7.3%) |
| Sept 2019 | - | $13.41 M(-6.7%) |
| June 2019 | - | $14.37 M(-2.3%) |
| Mar 2019 | - | $14.71 M(+0.1%) |
| Dec 2018 | $14.69 M(-51.6%) | $14.69 M(+14.2%) |
| Sept 2018 | - | $12.86 M(-48.7%) |
| June 2018 | - | $25.06 M(-5.3%) |
| Mar 2018 | - | $26.47 M(-12.8%) |
| Dec 2017 | $30.37 M(+138.9%) | $30.37 M(-3.6%) |
| Sept 2017 | - | $31.49 M(+102.0%) |
| June 2017 | - | $15.59 M(-9.7%) |
| Mar 2017 | - | $17.27 M(+35.9%) |
| Dec 2016 | $12.71 M(+48.2%) | $12.71 M(-6.7%) |
| Sept 2016 | - | $13.61 M(+88.3%) |
| June 2016 | - | $7.23 M(-8.8%) |
| Mar 2016 | - | $7.93 M(-46.6%) |
| Dec 2015 | $8.58 M(>+9900.0%) | - |
| Sept 2015 | - | $14.85 M(+243.8%) |
| June 2015 | - | $4.32 M(>+9900.0%) |
| Mar 2015 | - | $10.30 K(+14.4%) |
| Dec 2014 | $9000.00(-63.6%) | $9000.00(+291.3%) |
| Sept 2014 | - | $2300.00(+15.0%) |
| June 2014 | - | $2000.00(-58.3%) |
| Mar 2014 | - | $4800.00(-80.6%) |
| Dec 2013 | $24.70 K(-3.9%) | $24.70 K(-35.2%) |
| Sept 2013 | - | $38.10 K(+7.9%) |
| June 2013 | - | $35.30 K(+17.3%) |
| Mar 2013 | - | $30.10 K(+17.1%) |
| Dec 2012 | $25.70 K(+43.6%) | $25.70 K(+73.6%) |
| Sept 2012 | - | $14.80 K(+48.0%) |
| June 2012 | - | $10.00 K(+2.0%) |
| Mar 2012 | - | $9800.00(-45.3%) |
| Dec 2011 | $17.90 K(-64.6%) | $17.90 K(+132.5%) |
| Sept 2011 | - | $7700.00(-89.3%) |
| June 2011 | - | $72.30 K(+7.7%) |
| Mar 2011 | - | $67.10 K(+32.6%) |
| Dec 2010 | $50.60 K | $50.60 K(+25.9%) |
| Sept 2010 | - | $40.20 K(+20.0%) |
| June 2010 | - | $33.50 K(-5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $35.50 K(+198.3%) |
| Dec 2009 | $11.90 K(-43.9%) | $11.90 K(-68.4%) |
| Sept 2009 | - | $37.60 K(+3318.2%) |
| June 2009 | - | $1100.00(-87.9%) |
| Mar 2009 | - | $9100.00(-57.1%) |
| Dec 2008 | $21.20 K(-55.7%) | $21.20 K(+216.4%) |
| Sept 2008 | - | $6700.00(-6.9%) |
| June 2008 | - | $7200.00(-83.0%) |
| Mar 2008 | - | $42.30 K(-11.7%) |
| Dec 2007 | $47.90 K(-45.0%) | $47.90 K(+3.2%) |
| Sept 2007 | - | $46.40 K(-79.7%) |
| June 2007 | - | $229.10 K(-30.9%) |
| Mar 2007 | - | $331.70 K(+280.8%) |
| Dec 2006 | $87.10 K(-51.5%) | $87.10 K(-22.6%) |
| Sept 2006 | - | $112.60 K(-2.0%) |
| June 2006 | - | $114.90 K(+71.0%) |
| Mar 2006 | - | $67.20 K(-62.6%) |
| Dec 2005 | $179.50 K(-73.0%) | $179.50 K(+9.0%) |
| Sept 2005 | - | $164.70 K(-41.8%) |
| June 2005 | - | $283.10 K(-37.8%) |
| Mar 2005 | - | $454.90 K(-31.6%) |
| Dec 2004 | $665.10 K(+273.7%) | $665.10 K(-13.1%) |
| Sept 2004 | - | $765.10 K(+221.6%) |
| June 2004 | - | $237.90 K(+36.6%) |
| Mar 2004 | - | $174.20 K(-2.1%) |
| Dec 2003 | $178.00 K(-43.7%) | $178.00 K(-19.4%) |
| Sept 2003 | - | $220.80 K(-18.6%) |
| June 2003 | - | $271.20 K(+6.4%) |
| Mar 2003 | - | $255.00 K(-19.3%) |
| Dec 2002 | $316.00 K(-7.5%) | $316.00 K(-8.9%) |
| Sept 2002 | - | $346.70 K(-6.1%) |
| June 2002 | - | $369.10 K(+20.2%) |
| Mar 2002 | - | $307.10 K(-10.1%) |
| Dec 2001 | $341.50 K(-57.6%) | $341.50 K(-4.6%) |
| Sept 2001 | - | $358.00 K(-13.9%) |
| June 2001 | - | $415.80 K(-40.0%) |
| Mar 2001 | - | $692.60 K(-14.1%) |
| Dec 2000 | $806.30 K(-40.3%) | $806.30 K(-12.6%) |
| Sept 2000 | - | $922.40 K(-3.7%) |
| June 2000 | - | $957.70 K(-18.7%) |
| Mar 2000 | - | $1.18 M(-51.9%) |
| Dec 1999 | $1.35 M(-44.8%) | - |
| Dec 1998 | $2.45 M(+52.3%) | $2.45 M(+43.9%) |
| Sept 1998 | - | $1.70 M(+21.4%) |
| June 1998 | - | $1.40 M(-30.0%) |
| Mar 1998 | - | $2.00 M(+24.5%) |
| Dec 1997 | $1.61 M(+84.0%) | $1.61 M(+129.5%) |
| Sept 1997 | - | $700.00 K(0.0%) |
| June 1997 | - | $700.00 K(0.0%) |
| Mar 1997 | - | $700.00 K(-19.8%) |
| Dec 1996 | $873.30 K(+24.8%) | $873.30 K(+24.8%) |
| Sept 1996 | - | $700.00 K(0.0%) |
| June 1996 | - | $700.00 K(+16.7%) |
| Mar 1996 | - | $600.00 K(-14.3%) |
| Dec 1995 | $700.00 K(-30.0%) | $700.00 K(-70.8%) |
| Dec 1994 | $1.00 M(-58.3%) | - |
| Aug 1994 | - | $2.40 M |
| Aug 1994 | $2.40 M | - |
FAQ
- What is Enveric Biosciences annual total current liabilities?
- What is the all time high annual current liabilities for Enveric Biosciences?
- What is Enveric Biosciences annual current liabilities year-on-year change?
- What is Enveric Biosciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Enveric Biosciences?
- What is Enveric Biosciences quarterly current liabilities year-on-year change?
What is Enveric Biosciences annual total current liabilities?
The current annual current liabilities of ENVB is $2.34 M
What is the all time high annual current liabilities for Enveric Biosciences?
Enveric Biosciences all-time high annual total current liabilities is $30.37 M
What is Enveric Biosciences annual current liabilities year-on-year change?
Over the past year, ENVB annual total current liabilities has changed by -$1.65 M (-41.35%)
What is Enveric Biosciences quarterly total current liabilities?
The current quarterly current liabilities of ENVB is $839.20 K
What is the all time high quarterly current liabilities for Enveric Biosciences?
Enveric Biosciences all-time high quarterly total current liabilities is $31.49 M
What is Enveric Biosciences quarterly current liabilities year-on-year change?
Over the past year, ENVB quarterly total current liabilities has changed by -$3.34 M (-79.94%)